Filing Details

Accession Number:
0001213900-25-024133
Form Type:
13G Filing
Publication Date:
2025-03-13 20:00:00
Filed By:
Neurocords LLC
Company:
Orgenesis Inc. (PINK:ORGS)
Filing Date:
2025-03-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Neurocords LLC 0 1,200,000 18.84%
Ariel Malik 0 1,200,000 18.84%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Note for Rows 5, 7 and 9: Represents 1,200,000 shares of common stock of Orgenesis, Inc. (the "Issuer") held by Neurocords LLC, a Delaware limited liability company. The person having voting, dispositive or investment powers over Neurocords LLC is Ariel Malik. Ariel Malik is the manager and sole member of Neurocords LLC. Note for Row 11: Represents 18.84% of the 6,369,248 total outstanding shares of common stock; see Item 4.


SCHEDULE 13G



Comment for Type of Reporting Person:  Note for Rows 5, 7 and 9: Represents 1,200,000 shares of common stock held by Neurocords LLC, a Delaware limited liability company. The person having voting, dispositive or investment powers over Neurocords LLC is Ariel Malik. Ariel Malik is the manager and sole member of Neurocords LLC. Note for Row 11: Represents 18.84% of the 6,369,248 total outstanding shares of common stock; see Item 4.


SCHEDULE 13G


 
Neurocords LLC
 
Signature:/s/ Ariel Malik
Name/Title:Ariel Malik
Date:03/14/2025
 
Ariel Malik
 
Signature:/s/ Ariel Malik
Name/Title:Ariel Malik
Date:03/14/2025
Exhibit Information

Exhibit 1: Joint Filing Agreement